Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Cancer Res Ther ; 2020 Sep; 16(4): 946-949
Artigo | IMSEAR | ID: sea-213736

RESUMO

Synchronous malignancies arising from head and neck and thorax are rare presentation, and only few cases are reported in the scientific literature. We report three cases of double primary malignancies treated at our hospital.

2.
Artigo em Inglês | WPRIM | ID: wpr-761004

RESUMO

PURPOSE: There is sparse literature on treatment outcomes research on resectable oral tongue squamous cell carcinoma (OTSCC). The aim of this study was to measure the treatment outcomes, explore the failure patterns, and identify the potential clinicopathological prognostic factors affecting treatment outcomes for resectable OTSCC. MATERIALS AND METHODS: It is a retrospective analysis of 202 patients with resectable OTSCC who underwent upfront primary surgical resection followed by adjuvant radiotherapy with or without concurrent chemotherapy if indicated. RESULTS: The median follow-up was 35.2 months (range, 1.2 to 99.9 months). The median duration of locoregional control (LRC) was 84.9 months (95% confidence interval, 67.3–102.4). The 3- and 5-year LRC rate was 68.5% and 58.3%, respectively. Multivariate analysis showed that increasing pT stage, increasing pN stage, and the presence of extracapsular extension (ECE) were significantly associated with poorer LRC. The median duration of overall survival (OS) was not reached at the time of analysis. The 3- and 5-year OS rate was 70.5% and 66.6%, respectively. Multivariate analysis showed that increasing pT stage and the presence of ECE were significantly associated with a poorer OS. CONCLUSION: Locoregional failure remains the main cause of treatment failure in resectable OTSCC. There is scope to further improve prognosis considering modest LRC and OS. Pathological T-stage, N-stage, and ECE are strong prognostic factors. Further research is required to confirm whether adjuvant therapy adds to treatment outcomes in cases with lymphovascular invasion, perineural invasion, and depth of invasion, and help clinicians tailoring adjuvant therapy.


Assuntos
Humanos , Carcinoma de Células Escamosas , Tratamento Farmacológico , Células Epiteliais , Seguimentos , Neoplasias Bucais , Análise Multivariada , Avaliação de Resultados em Cuidados de Saúde , Prognóstico , Radioterapia , Radioterapia Adjuvante , Estudos Retrospectivos , Análise de Sobrevida , Língua , Falha de Tratamento , Resultado do Tratamento
3.
Radiation Oncology Journal ; : 341-347, 2018.
Artigo em Inglês | WPRIM | ID: wpr-741956

RESUMO

Surgical excision along with use of postoperative radiotherapy forms an integral management of sinonasal teratocarcinosarcoma (SNTCS). However, given the rarity of the tumor, no standardised guidelines, dose, technique and target delineation exist especially in the era of modern radiation delivery techniques. This is a case of 55-year-old male diagnosed as SNTCS treated with radical ethmoidectomy followed by volumetric modulated radiotherapy, showing good local control and acceptable toxicity profile.


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias de Cabeça e Pescoço , Radioterapia , Radioterapia de Intensidade Modulada
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA